SCHEMBL13978037

SCHEMBL13978037

SCc1[nH]cc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP1 P53582 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ CYP2A6 P11509 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ AHR P35869 2/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ IDO1 P14902 1/20 0.32
▸ HPRT1 P00492 1/20 0.32
▸ MC5R P33032 1/20 0.32
▸ MC1R Q01726 1/20 0.32
▸ HTR2A P28223 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28501579 0.82 TDP1 (0.40) METAP1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL292913 0.78 METAP1 (0.36) METAP1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL3875462 0.78 GPR84 (0.36) METAP1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL13977730 0.78 METAP1 (0.36) METAP1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL3430076 0.75 METAP1 (0.40) METAP1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL28691266 0.75 KMT2A (0.47) METAP1ALDH1A1MEN1KMT2AHPGD
SCHEMBL13376478 0.75 HTR2A (0.47) METAP1ALDH1A1HSD17B10CYP2A6TSHR
SCHEMBL3028098 0.75 METAP1 (0.40) METAP1ALDH1A1HSD17B10TDP1CYP2A6
SCHEMBL23421392 0.74 HTR2A (0.40) METAP1PARP1MEN1MAPTKMT2A
SCHEMBL27696265 0.74 ALDH1A1 (0.37) METAP1ALDH1A1HSD17B10TDP1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 — — US disclosed
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 — — US disclosed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION USP24, USP36, USP39 METAP1 2779/4885ALDH1A1 4211/4885HSD17B10 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback